Harvesting the Seeds from Funding Type 1 Diabetes Research
Diabetes Insights - Breakthroughs and InnovatorsShow Notes
In this episode, Elizabeth Robertson, Director of Research and Clinical at Diabetes UK, and Rachel Connor, Director of Research Partnerships at Breakthrough T1D, discuss why prevention has become one of the biggest topics in type 1 diabetes research.
They explore how decades of charity-funded research have led to exciting advances in immunotherapies that can delay the onset of type 1 diabetes, the growing importance of early screening programmes, and the promise of stem cell-derived beta cell therapies. They also explain why collaboration between researchers, charities, healthcare professionals, policymakers and people living with diabetes will be essential to ensure these breakthroughs become accessible treatments that improve lives worldwide.
More from Diabetes Insights - Breakthroughs and Innovators
In this EASD TV interview, Prof. Zachary Gerhart-Hines (Novo Nordisk Foundation Center for Basic Metabolic Research), 61st EASD Minkowski Prize recipient, discusses research into the neurokinin-2 receptor (NK2R) and its potential to change how we approach weight management and metabolic health. Where many existing treatments focus on reducing food intake, NK2R activation could offer a complementary strategy by increasing energy expenditure, influencing appetite and improving insulin sensitivity.
How does exercise stimulate glucose uptake in muscle and what can this teach us about treating type 2 diabetes?
Prof. Anette-Gabriele Ziegler, this year’s Claude Bernard Prize Lecture recipient, reflects on her career in type 1 diabetes research and the evolution of our understanding of the disease.
The EASD’s first clinical practice guideline on the assessment and management of diabetes distress in adults living with type 1 or type 2 diabetes has now been published in Diabetologia.
How can people living with diabetes help shape the future of diabetes care?